Latent tuberculosis infection among close contacts of multidrug-resistant tuberculosis patients in central Taiwan

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 11, 2010, Pages 1430-1435

  Huang, Yi Wen ^a   Shen, G H ^b   Lee, J J ^c   Yang, W T ^d  

^a Chang Hua Hospital   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d TAICHUNG HOSPITAL   (Taiwan)

Author keywords

Latent tuberculosis; Multidrug resistant; QuantiFERON TB Gold In Tube; Tuberculin skin test

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BACTERIAL TRANSMISSION; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HUMAN; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MONITORING; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TAIWAN; THORAX RADIOGRAPHY; TUBERCULIN TEST; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; BCG VACCINE; CONTACT TRACING; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; TAIWAN; TUBERCULIN TEST; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 78049443194     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. World Health Organization. Drug and multidrug-resistant tuberculosis (MDR-TB). Geneva, Switzerland: WHO, 2009. http://www.who.int/tb/challenges/mdr/ en/index.html Accessed December 2009.
2. Mazurek G H, Villarino M E. Guidelines for using the Quanti- FERON®-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for disease control and prevention. MMWR 2003; 52 (RR02): 15-18.
3. Mazurek G H, Jereb J, LoBue P, Iademarco M F, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB gold test for detecting Mycobacterium tuberculosis infection, United States. Centers for Disease Control and Prevention. MMWR 2005; 54 (RR15): 49-55.
4. Cellestis. QuantiFERON-TB Gold In-Tube method and technical information. Melbourne, VIC, Australia: Cellestis, 2009. http://www.cellestis.com/IRM/ Content/aust/qtfproducts-tbgoldintube-techinfo.html Accessed December 2009.
5. Pollock J M, McNair J, Bassett H, et al. Specific delayed-type hypersensitivity responses to ESAT-6 identify tuberculosis-infected cattle. J Clin Microbiol 2003; 41: 1856-1860.
6. Mahomed H, Hughes E J, Hawkridge T, et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-γ assay for tuberculosis infection. Int J Tuberc Lung Dis 2006; 10: 310-316.
7. Brock I, Munk M E, Kok-Jensen A, Andersen P. Performance of whole blood IFN-γ test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001; 5: 462-467. (Pubitemid 32397571)
8. Vordermeier H M, Chambers M A, Cockle P J, Whelan A O, Simmons J, Hewinson R G. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 2002; 70: 3026-3032.
9. Teixeira L, Perkins M D, Johnson J L, et al. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2001; 5: 321-328.
10. Kim E Y, Lim J E, Jung J Y, et al. Performance of the tuberculin skin test and interferon-γ release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis 2009; 9: 207.
11. Katial R K, Hershey J, Purohit-Seth T, et al. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture. Clin Diagn Lab Immunol 2001; 8: 339-345.
12. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Oka M. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from non-tuberculous mycobacteriosis. Clin Infect Dis 2006; 43: 1540-1546.
13. Vinton P, Mihrshahi S, Johnson P, et al. Comparison of QuantiFERON-TB Gold In-Tube test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol 2009; 30: 215-221.
14. Kunst H. Diagnosis of latent tuberculosis infection: the potential role of new technologies. Respir Med 2006; 100: 2098-2106. (Pubitemid 44724568)
15. Diel R, Loddenkemper R, Meywald-Walter K, et al. Comparative performance of tuberculin skin test, QuantiFERON-TB Gold In-Tube Assay, and T-SPOT.TB test in contact investigations for tuberculosis. Chest 2009; 135: 1010-1018.